Varicose veins show enhanced chemokine expression

Eur J Vasc Endovasc Surg. 2009 Nov;38(5):635-41. doi: 10.1016/j.ejvs.2009.07.021. Epub 2009 Sep 2.

Abstract

Objectives: Leucocyte infiltration in the wall of varicose veins has been reported previously. This study was designed to investigate the expression of pro-inflammatory cytokines and chemokines in control and in patients with varicose veins and to test the effect of treating varicose vein patients with acetylsalicylic acid (ASA) on cytokine expression prior to removal of varices.

Material and methods: Sections of vein were removed during operation from both patient groups, and ribonuclease protection assays (RPAs) were performed to assess the expression of chemokines. Group I included non-varicose saphenous veins from healthy patients undergoing amputation for trauma. Varicose veins were obtained from patients with primary varicose undergoing surgical treatment who received no drug (group II) or treatment with 300 mg day(-1) of ASA for 15 days before surgery (group III).

Results: Non-varicose veins constitutively expressed low levels of monocyte-chemoattractant protein (MCP-1) and interleukin (IL)-8 mRNA. Varicose veins had a distinct chemokine expression pattern, since significant up-regulation of MCP-1 and IL-8 and a marked expression of IP-10, RANTES, MIP-1alpha and MIP-1beta mRNA were detected. Removal of the endothelium did not alter this pattern. Varicose veins obtained from patients treated with ASA showed a consistent decrease in chemokine expression, although it did not reach statistical significance.

Conclusions: Varicose veins showed increased expression of several chemokines compared to control veins. A non-significant reduction of activation was observed following treatment with ASA for 15 days.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / administration & dosage*
  • Aspirin / administration & dosage*
  • Chemokines / genetics
  • Chemokines / metabolism*
  • Combined Modality Therapy
  • Cytokines / genetics
  • Cytokines / metabolism*
  • Double-Blind Method
  • Drug Administration Schedule
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / immunology
  • Female
  • Humans
  • Inflammation Mediators / metabolism*
  • Male
  • Middle Aged
  • Platelet Aggregation Inhibitors / administration & dosage*
  • RNA, Messenger / metabolism
  • Saphenous Vein / drug effects*
  • Saphenous Vein / immunology
  • Saphenous Vein / surgery
  • Treatment Outcome
  • Up-Regulation
  • Varicose Veins / drug therapy*
  • Varicose Veins / immunology
  • Varicose Veins / surgery
  • Vascular Surgical Procedures

Substances

  • Anti-Inflammatory Agents
  • Chemokines
  • Cytokines
  • Inflammation Mediators
  • Platelet Aggregation Inhibitors
  • RNA, Messenger
  • Aspirin